publication date: Apr. 26, 2019

In Brief

$15.1M awarded to Rutgers Cancer Institute of New Jersey for redesignation as Comprehensive Cancer Center

Rutgers Cancer Institute of New Jersey has been awarded a $15.1 million grant (P30CA072720) as part of its successful 2019 redesignation as a Comprehensive Cancer Center.

In its comprehensive on-site review of Rutgers Cancer Institute programs, NCI recognized the Institute’s treatment, prevention, education and outreach efforts as well as acknowledged its value as a collaborative matrix/consortium cancer center between Rutgers, The State University of New Jersey and Princeton University.

Rutgers Cancer Institute collaborates with Princeton University as part of a research consortium.

This partnership provides continued opportunities for scientific collaboration and cooperative use of state-of-the-art shared resources. As a result of this relationship, scientific advances in the areas of cancer metabolism, metastasis, and genomics have contributed to impactful clinical progress in areas such as precision medicine and immunotherapy.

As an NCI-approved consortium partner, Princeton is considered part of the Rutgers Cancer Institute. 

In this latest review, the NCI affirmed the entire state of New Jersey as Rutgers Cancer Institute’s catchment area.

Also highlighted were efforts by Rutgers Cancer Institute research members in examining tobacco regulation and the impact on tobacco control policies, as well as the support of public health initiatives—including the recently developed ScreenNJ initiative with the New Jersey Department of Health to enhance cancer screening, prevention and education activity.


Inova dedicates Inova Schar Cancer Institute; John Deeken named president

The Inova Schar Cancer Institute will open its doors to patients on May 13. The center, which is a part of the Inova Health System and Inova Fairfax Hospital, offers … Continue reading $15.1M awarded to Rutgers Cancer Institute of New Jersey for redesignation as Comprehensive Cancer Center

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.